Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 70518-4198

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-4198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a 25 mg Metoprolol Succinate extended-release tablet prescription, with a quantity of 90 tablets. The manufacturer is Ascend Labs, LLC based in Montvale, NJ. The medication should be stored at 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F). For more information on usage, refer to the package insert. Keep out of reach of children.*
FDA Label Image

Metoprolol-structure (Metoprolol Structure)

FDA Label Image

Metoprolol-table1a (Metoprolol Table1a)

Metoprolol-table1a (Metoprolol Table1a)
This is a report on the results of subgroups in the MERIT-HF study related to total mortality, all-cause hospitalization, and heart failure outcomes. The study compares the effects of Metoprolol Succinate Extended-Release tablets with a placebo on different subgroups including NYHA classification, ejection fraction, etiology of heart failure, sex, race, history of myocardial infarction, diabetes mellitus, hypertension, and heart rate. The study presents relative risk and 95% confidence intervals for each subgroup.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.